Completed Transaction To Make Myovant Sciences A Wholly Owned Unit Of Sumitovant
March 13 (Reuters) - Sumitomo Pharma Co Ltd 4506.T :
* SUMITOMO PHARMA, SUMITOVANT BIOPHARMA, AND MYOVANT
SCIENCES
COMPLETE TRANSACTION TO MAKE MYOVANT SCIENCES A WHOLLY OWNED
UNIT OF SUMITOVANT
Source text for Eikon: ID:nTSol8100d
Further company coverage: 4506.T
Recent news on Sumitomo Pharma
See all newsSumitomo Pharma America Announces First Patient Receives Treatment In Phase 1/2A Study For Investigational Therapy Dsp-3077 For Retinitis Pigmentosa
Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report)
Brief: Sumitomo Pharma - Gotham City Research's August 3 Report Contains Numerous Statements That Are Clearly Inconsistent With Facts
Brief: Gotham City Research Holds Short Positions In Sumitomo Chemical And Sumitomo Pharmaceutical
Table: Sumitomo Pharma -Q1 group results (IFRS)